tiprankstipranks
BeOne Medicines Ltd (HK:6160)
:6160
Hong Kong Market

Compare BeOne Medicines Ltd (6160) vs. Competitors

22 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
BeOne Medicines Ltd
HK$182.30
HK$280.59B
124.75
36.87%
5 Buy
0 Hold
0 Sell
Strong Buy
Innovent Biologics
HK$86.90
HK$153.56B
144.97
81.99%
14 Buy
0 Hold
0 Sell
Strong Buy
Wuxi Biologics (Cayman)
HK$35.28
HK$148.55B
11.12
76.93%
11 Buy
1 Hold
0 Sell
Strong Buy
WuXi AppTec Co., Ltd. Class H
HK$128.40
HK$359.49B
8.95
150.29%
5 Buy
0 Hold
0 Sell
Strong Buy
Hansoh Pharmaceutical Group Company Limited
HK$38.46
HK$234.70B
35.71
70.18%
7 Buy
0 Hold
0 Sell
Strong Buy
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H
HK$63.35
HK$432.01B
55.67
17.32%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:6160
BeOne Medicines Ltd
187.10
39.00
26.33%
HK:1801
Innovent Biologics
86.90
38.50
79.55%
HK:2269
Wuxi Biologics (Cayman)
35.28
14.08
66.42%
HK:2359
WuXi AppTec Co., Ltd. Class H
128.40
76.80
148.84%
HK:3692
Hansoh Pharmaceutical Group Company Limited
38.46
15.91
70.55%
HK:1276
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H
64.70
11.00
20.48%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts